Elsevier

Molecular Brain Research

Volume 3, Issue 1, December 1987, Pages 39-43
Molecular Brain Research

Research report
Neuropeptide Y gene expression in PC12 cells and its regulation by nerve growth factor: a model for developmental regulation

https://doi.org/10.1016/0169-328X(87)90042-8Get rights and content

Abstract

Neuropeptide Y (NPY) is a 36 amino acid neuronal peptide which has previously been described within a subset of sympathetic neurons. The presence of the messenger RNA that encodes NPY (NPY mRNA) has been studied in the PC12 cell line, as this is commonly used as a model of neuronal differentiation. Low levels of the NPY mRNA were identified in resting naive cells. Levels were induced five-fold by the addition of nerve growth factor to the medium at a dose of 30 ng/ml. Lower doses of nerve growth factor had no effect on NPY mRNA. The effect was rapid in onset being apparent within 12 h and near maximal at 24 h. A smaller two-fold increase in NPY mRNA was observed in cells treated with epidermal growth factor (3 ng/ml) over the same time course but no effect was observed with fibroblast growth factor (3 ng/ml), bradykinin (10−6 M) or dexamethasone (10−6 M). These results indicate that NPY gene expression is regulated in PC12 cells at the level of NPY mRNA.

Cited by (57)

  • Hypothalamic cell lines to investigate neuroendocrine control mechanisms

    2009, Frontiers in Neuroendocrinology
    Citation Excerpt :

    There are excellent reviews on GnRH promoter analysis [19,66,114], and therefore this will not be further covered in this review. However, relatively little has been reported about the regulation of the NPY promoter [7,96,108,109,159], and these studies were only performed in heterologous cell models. It is known from bilateral neural transection experiments and antisense data that the NPY neurons responsible for the reproductive and orexigenic effects of NPY lie within defined regions of the hypothalamus, including the arcuate nucleus [81,133,134], which clearly are not represented by any of the tumor-derived cell lines previously used for NPY studies.

  • Neuropeptide Y in neural crest-derived tumors: Effect on growth and vascularization

    2007, Cancer Letters
    Citation Excerpt :

    Moreover, lack of NPY distinguishes central primitive neuroectodermal tumors (cPNET) from their NPY-rich peripheral counterparts (pPNET) belonging to the ESFT [31]. Due to the abundance of NPY and its receptors, tumors of the autonomic nervous system have been widely used to study the regulation of peptide expression, its signaling, and functions of the receptors [32–34]. However, till now, NPY was considered merely a marker of neuronal differentiation and nothing was known about its actual function in these tumors.

View all citing articles on Scopus
View full text